In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on Agios Pharma (AGIO – Research Report), with a price target ...
David Schenkein will step down from Agios Pharmaceuticals ’ board of directors at the end of the month “to devote more ...
In a report released yesterday, Gregory Renza from RBC Capital maintained a Buy rating on Agios Pharma (AGIO – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results